Sign Up for Our E-Newsletter

In The News

Sedasys: The Machine that Sedates

Posted on May 18, 2015


Imagine a day when you go in for a colonoscopy and a machine, not a person, sedates you. You may be familiar with this reality if you’ve come across Sedasys—an FDA-approved anesthesiology machine developed by Johnson & Johnson.

Read more

U.S. Department of Health and Human Services Clarifies Preventive Screening Coverage

Posted on May 12, 2015


You may have heard that the U.S. Department of Health and Human Services (HHS) just clarified the Affordable Care Act’s policy on preventative care coverage regarding anesthesia services. The HHS made it clear that insurance companies can’t make you pay for anesthesia services related to preventive colonoscopies if the attending provider determines that anesthesia would be medically appropriate for the patient.

Read more

Colon Health Alert: FDA Approves Second-Line Use of Cyramza

Posted on May 1, 2015

Colon Health Alert_square

Eli Lilly and Company recently announced that the FDA has approved the use of Cyramza with FOLFIRI as a second-line treatment for colorectal cancer. This treatment, previously approved for use with advanced or metastatic gastric and lung cancer, now provides metastatic colorectal cancer patients with another biologic to use in the fight against their disease.

Read more

21st Century Cures Initiative: Legislation We Need Now

Posted on April 30, 2015

U.S. capitol building

For the past year, members of the House Energy and Commerce Committee have asked patients, doctors, researchers and regulators:

  1. What needs to be done to develop new treatments and cures?
  2. How can we get these new therapies to patients faster? Read more

New Funding Awarded for Under 50 Research

Posted on April 22, 2015

2015 Blue Hope Research Award

Scientific research is crucial to better understand the causes and factors associated with colon cancer. That’s why we established the Blue Hope Research Award, a one-year fellowship providing vital resources and funding to a bright investigator interested in making his or her mark in the colon cancer space.

Last year, we used the American Association for Cancer Research’s (AACR) peer-review process to fund critical research on biomarkers. We’re excited to announce that last night we officially presented our second annual Blue Hope Research award to Kent W. Mouw, M.D., Ph.D from the Dana-Farber Cancer Institute at the AACR’s Annual Meeting in Philadelphia, PA. Read more